S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom

Harpoon Therapeutics (HARP) Insider Trading & Ownership

$23.01
0.00 (0.00%)
(As of 03/11/2024)

Harpoon Therapeutics (NASDAQ:HARP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
17.00%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$492.14 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get HARP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Harpoon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HARP Insider Buying and Selling by Quarter

Harpoon Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/11/2024Merck & Co., Inc.Major ShareholderBuy21,397,205$23.00$492,135,715.00  
(Data available from 1/1/2013 forward)

HARP Insider Trading Activity - Frequently Asked Questions

Who is on Harpoon Therapeutics's Insider Roster?

The list of insiders at Harpoon Therapeutics includes Ansbert Gadicke, Georgia Erbez, Holger Wesche, Impact Fund (Cayman) Oncology, Merck & Co., Inc., and Ronald Hunt. Learn more on insiders at HARP.

What percentage of Harpoon Therapeutics stock is owned by insiders?

17.00% of Harpoon Therapeutics stock is owned by insiders. Learn more on HARP's insider holdings.

Which Harpoon Therapeutics insiders have been buying company stock?

The following insiders have purchased HARP shares in the last 24 months: Merck & Co., Inc. ($492,135,715.00), and Ronald Hunt ($10,000,000.00).

How much insider buying is happening at Harpoon Therapeutics?

Insiders have purchased a total of 21,398,205 HARP shares in the last 24 months for a total of $502,135,715.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:HARP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners